Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $98.15 | 6 | 86.0% |
| Education | $16.02 | 1 | 14.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $70.15 | 4 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $16.02 | 1 | $0 (2019) |
| Mission Pharmacal Company | $15.39 | 1 | $0 (2017) |
| Horizon Pharma plc | $12.61 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $53.07 | 3 | Genentech USA, Inc. ($53.07) |
| 2019 | $16.02 | 1 | Merck Sharp & Dohme Corporation ($16.02) |
| 2018 | $17.08 | 1 | Genentech USA, Inc. ($17.08) |
| 2017 | $28.00 | 2 | Mission Pharmacal Company ($15.39) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $21.88 | General |
| Category: Virology & Specialty Care | ||||||
| 01/24/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Virology & Specialty Care | ||||||
| 01/21/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Virology & Specialty Care | ||||||
| 07/17/2019 | Merck Sharp & Dohme Corporation | — | Education | In-kind items and services | $16.02 | General |
| 11/12/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Virology & Specialty Care | ||||||
| 04/28/2017 | Horizon Pharma plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: DUEXIS | ||||||
| 02/10/2017 | Mission Pharmacal Company | Uribel (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Analgesic, antispasmodic & antiseptic (urinary) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 900 | 1,589 | $87,503 | $33,542 |
| 2022 | 14 | 876 | 1,502 | $85,153 | $40,501 |
| 2021 | 18 | 1,381 | 2,295 | $127,724 | $66,521 |
| 2020 | 22 | 1,571 | 2,651 | $119,268 | $52,083 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 128 | $25,503 | $10,004 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 91 | 107 | $15,385 | $6,088 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $13,004 | $5,895 | 45.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 64 | 64 | $11,223 | $4,448 | 39.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 53 | 53 | $4,688 | $2,665 | 56.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 136 | 241 | $6,971 | $2,124 | 30.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 29 | 56 | $2,250 | $908.32 | 40.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 44 | 46 | $2,102 | $351.40 | 16.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 45 | 46 | $552.00 | $350.06 | 63.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 12 | 14 | $350.00 | $230.44 | 65.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 17 | 19 | $304.00 | $196.65 | 64.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 39 | 43 | $215.00 | $146.63 | 68.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 91 | 237 | $4,740 | $82.82 | 1.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 108 | 445 | $178.00 | $36.80 | 20.7% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 13 | 40 | $40.00 | $13.89 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 147 | $22,924 | $13,162 | 57.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 103 | 115 | $12,454 | $7,366 | 59.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $11,329 | $6,570 | 58.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 109 | 114 | $17,100 | $5,782 | 33.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 57 | 57 | $7,538 | $4,553 | 60.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 127 | 212 | $5,905 | $1,957 | 33.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $576.00 | $390.27 | 67.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 24 | 25 | $585.00 | $192.01 | 32.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 42 | 51 | $485.00 | $175.26 | 36.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 11 | 12 | $228.00 | $125.75 | 55.2% |
About Dr. Ryan Gregorio, MD
Dr. Ryan Gregorio, MD is a Family Medicine healthcare provider based in Russellville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1285849729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Gregorio, MD has received a total of $114.17 in payments from pharmaceutical and medical device companies, with $53.07 received in 2020. These payments were reported across 7 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($98.15).
As a Medicare-enrolled provider, Gregorio has provided services to 4,728 Medicare beneficiaries, totaling 8,037 services with total Medicare billing of $192,647. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Russellville, AL
- Active Since 05/10/2007
- Last Updated 03/07/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1285849729
Products in Payments
- Xofluza (Drug) $70.15
- Uribel (Drug) $15.39
- DUEXIS (Drug) $12.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Russellville
Dr. Harry Kuberg, M.d, M.D
Family Medicine — Payments: $16,095
Dr. Steven Zeller, M.d, M.D
Family Medicine — Payments: $8,880
Kevin Kelly
Family Medicine — Payments: $5,632
Katherine Gilliam, Do, DO
Family Medicine — Payments: $5,253
Nathan Nielson, Do, DO
Family Medicine — Payments: $3,724
Chenyi Chenyi, Md, MD
Family Medicine — Payments: $1,515